George Mussalli was featured in Arthur Villasanta’s article “Coronavirus Vaccine Unlikely To Arrive in 2020: ‘It Doesn’t Look Very Promising,'” published by the International Business Times.

“The latest expert source to attest to this impossibility used its experience in quantitative financial investment to analyze the progress being made by the 60 vaccine candidates. Boston-based PanAgora Asset Management analyzed vast quantities of medical research data to calculate which of the 60 will succeed in producing a successful vaccine within the year. The quick answer is “zero.”